9
19
カタログ番号 | 製品名 | 別名 | ターゲット |
---|---|---|---|
T9080 | Plecanatide | Guanylate cyclase | |
Plecanatide acetate is an analogue of Uroguanylin. It is an orally active guanylate cyclase-C (GC-C) receptor agonist. | |||
T11852 | Linaclotide | Guanylate cyclase | |
Linaclotide developed for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation, and is a potent and selective guanylate cyclase C agonist. | |||
T12501 | Plecanatide acetate | Others | |
Plecanatide acetate is a agonist of guanylate cyclase-C (GC-C) receptor( EC50 of 190 nM in T84 cells), and shows anti-inflammatory activity in models of murine colitis. | |||
T11852L | Linaclotide acetate | MM 416775,MM416775 MD-1100 acetate,Linzess,MM-416775 | |
Linaclotide acetate is used as an oral guanylate cyclase C agonist linaclotide; 14 amino acid peptide for the potential treatment of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation. | |||
T38482 | MM 419447 | ||
MM 419447 is a guanylate cyclase-C agonist, and it is a metabolite of linaclotide. This compound, MM 419447, shows promise in the field of irritable bowel syndrome with constipation (IBS-C) research. | |||
T76274 | Dolcanatide | ||
Dolcanatide, an orally active guanylate cyclase-C (GC-C) agonist, exhibits laxative, anti-nociceptive, and anti-inflammatory properties. It is utilized in research concerning inflammatory bowel disease [1] [2]. | |||
T80067 | Uroguanylin (human) | Guanylate cyclase | |
Uroguanylin (human) serves as a natural ligand for the Guanylyl Cyclase C (GCC) receptor in metastatic colorectal cancer tumors and exhibits anti-tumor effects in an animal model of human colon cancer [1] [2]. | |||
T76363 | [Tyr22] Calcitonin Gene Related Peptide, (22-37), rat | ||
[Tyr22] Calcitonin Gene Related Peptide (22-37), rat, refers to a fragment (amino acids 22-37) of the rat calcitonin gene-related peptide (CGRP) that targets the CGRP receptor and adenylate cyclase. While calcitonin is p... | |||
T76334 | Cenderitide | ||
Cenderitide, a natriuretic peptide (NP) that combines C-type natriuretic peptide (CNP) with the C-terminus of Dendroaspis natriuretic peptide (DNP), serves as a potent agonist of the particulate guanylyl cyclase receptor... |
カタログ番号 | 製品名 | Species | Expression System |
---|---|---|---|
TMPJ-00910 | GUCY2C Protein, Human, Recombinant (His & Avi), Biotinylated | Human | HEK293 Cells |
GUCY2C Protein, Human, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-6xHis-Avi tag. The predicted molecular weight is 65-110 KDa and the accession number is P25092. | |||
TMPJ-00911 | GUCY2C Protein, Human, Recombinant (hFc) | Human | HEK293 Cells |
GUCY2C Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with C-Fc tag. The predicted molecular weight is 90-120 KDa and the accession number is P25092. | |||
TMPK-00990 | GUCY2C Protein, Mouse, Recombinant (His & Avi) | Mouse | HEK293 Cells |
Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier functio... | |||
TMPK-01279 | GUCY2C Protein, Cynomolgus, Recombinant (aa 24-430, His) | Cynomolgus | HEK293 Cells |
Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier functio... | |||
TMPK-00856 | GUCY2C Protein, Human, Recombinant (His & Avi) | Human | HEK293 Cells |
Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier functio... | |||
TMPK-01388 | GUCY2C Protein, Canine, Recombinant (aa 21-430, His) | Canine | HEK293 Cells |
Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier functio... | |||
TMPK-00991 | GUCY2C Protein, Mouse, Recombinant (His & Avi), Biotinylated | Mouse | HEK293 Cells |
Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier functio... | |||
TMPH-02993 | DisA Protein, Mycobacterium paratuberculosis, Recombinant (His & Myc) | Mycobacterium paratuberculosis | E. coli |
Participates in a DNA-damage check-point. DisA forms globular foci that rapidly scan along the chromosomes searching for lesions.; Has also diadenylate cyclase activity, catalyzing the condensation of 2 ATP molecules int... | |||
TMPH-01386 | GLP2R Protein, Human, Recombinant (His) | Human | HEK293 Cells |
This is a receptor for glucagon-like peptide 2. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. GLP2R Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with... | |||
TMPH-01715 | CHRM2 Protein, Human, Recombinant (His) | Human | E. coli |
The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. ... | |||
TMPH-01378 | GIPR Protein, Human, Recombinant (His & Myc) | Human | HEK293 Cells |
This is a receptor for GIP. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. GIPR Protein, Human, Recombinant (His & Myc) is expressed in HEK293 mammalian cells with N-10xHis and C... | |||
TMPH-00632 | Heat-labile enterotoxin B chain Protein, E. coli, Recombinant (His & Myc) | E. coli | E. coli |
The biological activity of the toxin is produced by the A chain, which activates intracellular adenyl cyclase. Heat-labile enterotoxin B chain Protein, E. coli, Recombinant (His & Myc) is expressed in E. coli expression ... | |||
TMPH-02022 | RXFP2 Protein, Human, Recombinant (His & Myc) | Human | E. coli |
Receptor for relaxin. The activity of this receptor is mediated by G proteins leading to stimulation of adenylate cyclase and an increase of cAMP. May also be a receptor for Leydig insulin-like peptide (INSL3). RXFP2 Pro... | |||
TMPH-00985 | NPR3 Protein, Human, Recombinant (His) | Human | E. coli |
Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance... | |||
TMPH-03250 | NPR3 Protein, Rat, Recombinant (His & SUMO) | Rat | E. coli |
Receptor for the natriuretic peptide hormones, binding with similar affinities atrial natriuretic peptide NPPA/ANP, brain natriuretic peptide NPPB/BNP, and C-type natriuretic peptide NPPC/CNP. May function as a clearance... | |||
TMPY-02236 | PTH1R Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Parathyroid hormone / parathyroid hormone-related peptide receptor, also known as PTH / PTHrP type I receptor, PTH/PTHr receptor, Parathyroid hormone 1 receptor, PTH1 receptor, PTH1R and PTHR, is a multi-pass membrane pr... | |||
TMPK-01456 | HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr... | |||
TMPK-01451 | HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi) | Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr... | |||
TMPK-01450 | HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated | Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-pr... |